Trafalgar International, Inc. SEC filings TRFA
Trafalgar International, Inc. has 144 filings in SEC EDGAR's recent list, going back to Jun 20, 2017. Its latest annual report, Form 10-K, was filed on Mar 31, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Aug 14, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Oct 14, 2026 (bylaw or fiscal year change, other events). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| 8-K |
Current report
Bylaw or fiscal year change, Other events
|
Oct 14, 2026 | Oct 12, 2026 |
| 8-K |
Current report
Officer or director change
|
Sep 21, 2026 | Sep 18, 2026 |
| 8-K |
Current report
Officer or director change, Bylaw or fiscal year change, Other events
|
Jul 31, 2026 | Jul 29, 2026 |
| 8-K |
Current report
Material agreement, Change in control, Officer or director change
|
Jul 6, 2026 | Jun 29, 2026 |
| 8-K |
Current report
Bylaw or fiscal year change, Other events
|
Oct 27, 2025 | Oct 22, 2025 |
| 8-K/A |
Amended current report
Bylaw or fiscal year change, Other events
|
Oct 16, 2025 | Oct 15, 2025 |
| 8-K |
Current report
Bylaw or fiscal year change, Other events
|
Oct 15, 2025 | Oct 15, 2025 |
| 8-K |
Current report
Unregistered share sale, Officer or director change
|
Apr 10, 2025 | Apr 3, 2025 |
| 8-K |
Current report
Auditor change
|
Mar 6, 2025 | Mar 6, 2025 |
| 8-K |
Current report
Bylaw or fiscal year change
|
Aug 16, 2023 | Jun 13, 2023 |
| 8-K |
Current report
Auditor change
|
Jan 26, 2023 | Jan 25, 2023 |
| 8-K |
Current report
Material agreement
|
Jun 21, 2022 | Jun 19, 2022 |
| 8-K |
Current report
Material agreement
|
May 19, 2022 | May 18, 2022 |
| 8-K/A |
Amended current report
Auditor change
|
Nov 10, 2021 | Aug 1, 2021 |
| 8-K |
Current report
Agreement ended, Officer or director change
|
Nov 1, 2021 | Oct 25, 2021 |
| 8-K |
Current report
Officer or director change, Other events
|
Aug 19, 2021 | Aug 19, 2021 |
| 8-K |
Current report
Auditor change
|
Aug 4, 2021 | Aug 1, 2021 |
| 8-K |
Current report
Material agreement, New debt
|
Mar 16, 2021 | Mar 15, 2021 |
| 8-K |
Current report
Material agreement
|
May 28, 2020 | May 26, 2020 |
| 8-K |
Current report
Material agreement, New debt
|
Feb 3, 2020 | Jan 27, 2020 |
| 8-K |
Current report
Material agreement, New debt
|
Oct 23, 2019 | Oct 18, 2019 |
| 8-K |
Current report
Material agreement, New debt
|
Feb 15, 2019 | Feb 12, 2018 |
| 8-K/A | Amended current report | Nov 15, 2018 | Jul 31, 2018 |
| 8-K |
Current report
Officer or director change, Regulation FD disclosure
|
Sep 27, 2018 | Sep 26, 2018 |
| 8-K |
Current report
Material agreement, Acquisition or sale of assets, Change in control, Officer or director change
|
Aug 3, 2018 | Jul 31, 2018 |
| 8-K |
Current report
Material agreement, New debt, Unregistered share sale
|
Jun 15, 2018 | Jun 13, 2018 |
| 8-K |
Current report
Material agreement, New debt, Unregistered share sale
|
May 17, 2018 | Mar 28, 2018 |
| 8-K |
Current report
Material agreement, New debt, Unregistered share sale
|
Apr 2, 2018 | Jan 9, 2018 |
| 8-K |
Current report
Restatement
|
Feb 6, 2018 | Jan 26, 2018 |
| 8-K |
Current report
Material agreement, Unregistered share sale
|
Sep 19, 2017 | Sep 15, 2017 |
Showing 30 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- TRFA (OTC)
- Fiscal year ends
- December 31
- Incorporated in
- FL
- Headquarters
- Miami, FL
- SEC filer status
- Non-accelerated filer, Smaller reporting company
- SEC CIK
- 1695473
- Former names
- Greater Cannabis Company, Inc. (until Jul 31, 2026)
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Source: SEC EDGAR filings. This is company-reported data, not investment advice.